Cara Therapeutics, Inc.
Edit

Cara Therapeutics, Inc.

http://www.caratherapeutics.com/
Last activity: 07.03.2024
Categories: BioTechHealthTechMedTech
Summary: Cara Therapeutics is a biotechnology company focused on developing novel, superior therapeutics to treat pain and inflammation associated with diverse medical conditions.
Mentions
10
Total raised: $15M

Investors 4

Funding Rounds 1

DateSeriesAmountInvestors
21.07.2010Series D$15M-

Mentions in press and media 10

DateTitleDescriptionSource
07.03.2024Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual...-globenewsw...
02.11.2023Cara Therapeutics Announces up to $40.0 Million Non-Dilutive...-globenewsw...
25.02.2022Kapruvia® receives positive CHMP opinion for the treatment o...Committee for Medicinal Products for Human Use (CHMP) recommends approval of Kapruvia® (difelikefali...globenewsw...
03.01.2018Centrexion’s $67M Series D round to fund Phase 3 pain studie...Despite being just four years old, Centrexion is building a significant pipeline of non-opioid, non-...medcitynew...
30.06.2017Cara Therapeutics: A lesson in clinical trial failure and sp...Cara Therapeutics tried to misdirect investors away from the failure of its osteoarthritis pain pill...statnews.c...
29.06.2016The biotech IPO feast flags as in­vestors lose their ap­peti...There was a time af­ter the 2008 crash that biotech IPOs were about as pop­u­lar as snow in March. B...endpts.com...
21.07.2010Cara Therapeutics Raises $15m in Series D FinancingCara Therapeutics, Inc., a Shelton, CT-based biotechnology company focused on developing novel thera...finsmes.co...
27.09.2007Life sciences briefing: Thursday, Sept. 27, 2007Featured companies: AstraZeneca, Atlantis Components, Cara Therapeutics, CardioMems, Corium Internat...venturebea...
-Stocks making the biggest moves midday: Best Buy, Palo Alto ...Check out the companies making headlines in midday trading. Best Buy — The electronics retailer’s sh...cnbc.com/2...
-Centrexion’s $67M Series D round to fund Phase 3 pain studie...Boston-based Centrexion Therapeutics has finalized $67 million in Series D financing to fund upcomin...medcitynew...

Reviews 0

Sign up to leave a review

Sign up Log In